Actively Recruiting
Study on the Incidence and Course of Pediatric Acute-Onset Neuropsychiatric Syndrome PANS and PANDAS in Children Aged 3 to 17
Led by University of Wisconsin, Madison · Updated on 2026-01-27
30
Participants Needed
2
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying the feasibility of enrolling and following children diagnosed with Pediatric Acute-Onset Neuropsychiatric Syndrome PANS and Pediatric Autoimmune Neuropsychiatric Disorder Associated with Streptococcus PANDAS. The study aims to track the incidence, spectrum, course, and outcomes of these disorders over one year, focusing on children aged 3 to 17 years. The goal includes demonstrating the ability to recruit and retain at least 85% of eligible participants. The study includes two groups children from primary care populations at UW Health or Dartmouth Health, and children from external specialty clinics. Participants will be identified soon after symptom onset and monitored over one year. The study collects information about the role of Group A streptococcus infections and the clinical progression of PANSPANDAS in these children. Participants and their parents or guardians will complete study activities in English and attend visits at baseline and follow-ups during the year. Researchers will assess enrollment rates, retention, and the natural history of symptoms using medical records and questionnaires. The main outcome measured is the percentage of eligible children enrolled, with retention rates monitored at 12 months.
CONDITIONS
Brief Title
PEDI Pediatric Autoimmune Neuropsychiatric Disorder Associated With Streptococcus Study
Research Team
P
Pediatric Clinical Research Coordination
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here